Oncology Trial Activation Manager
OHSU Knight Cancer Institute, Knight Cancer Clinical Research
Salary Range: $93,392 - $149,156/yr based on education/experience
FTE 1.00 (hybrid, in-person)
Department Overview
The mission of the Knight Cancer Clinical Research organization is to support translational clinical research aimed at improving the lives of people and families with cancer by applying innovative strategies for cancer prevention, screening, diagnosis, and treatment. Support is provided through proactive, high-quality, efficient study management in compliance with federal regulations and local policies. This fast-paced, intensive research environment involves complex clinical studies in a highly vulnerable patient population.
Function/Duties of Position
Position Summary:
This position is responsible for oversight and improvement of activation of therapeutic interventional trials at OHSU Knight Cancer Clinical Research (KCCR). The successful candidate will identify bottlenecks, implement measurable process improvements, align stakeholders, and build a culture of accountability and speed while maintaining compliance, quality, and patient safety. Responsibilities include oversight of activation processes and development of SOPs and tools to streamline trial activation. The Activation Manager will track start-up metrics, communicate with process owners and stakeholders, and implement operational efficiencies.
Success will be demonstrated through implementation of processes resulting in significant, sustainable reductions in median trial activation timelines.
Duties & Responsibilities:
Strategic Leadership & Process Transformation
Stakeholder Management
Partner with investigators, department leaders, sponsors, CROs, and institutional teams (IRB, legal, finance, contracting, compliance) to prioritize studies and remove activation barriers
Change Management
Standardization Across Disease Programs
Required Qualifications
For additional details and to apply, visit the OHSU Jobs link: Oncology Trial Activation Manager.